companydata.dkcompanydata.dk

Hoba Therapeutics ApS: Financial statements 2021

CVR: 38231170

Source: annual report 2021, Danish Business Authority

01/04/2020 – 31/03/2021

Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,392,884 and a net result of DKK -1,944,679 compared with DKK -1,582,107 the year before. That is an increase of 66% compared with the year before. Equity in the 2021 report amounted to DKK 8,183,648. The solvency ratio was 22.4%. The company had 3 employees in the financial year.

Gross Profit
DKK 1,392,884
Profit/Loss
DKK -1,944,679
Equity
DKK 8,183,648
Total Assets
DKK 36,460,947
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-1.4M-1.9M8.2M3
2020-839K-1.6M10.1M2
2019-296K-1.1M11.7M-
2018-485K-892K8.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Hoba Therapeutics ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Camilla Petrycer Hansen joins the board of Hoba Therapeutics ApSAug 24, 2021

As of August 24, 2021, Camilla Petrycer Hansen has joined the board of directors of Hoba Therapeutics ApS.

About Hoba Therapeutics ApS

Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.

Source: annual report 2026, Danish Business Authority